{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:47:16Z","timestamp":1785908836054,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Healthy Zhejiang One Million People Cohort","award":["K20230085"],"award-info":[{"award-number":["K20230085"]}]},{"name":"Zhejiang Key Laboratory of Intelligent Preventive Medicine","award":["2020E10004"],"award-info":[{"award-number":["2020E10004"]}]},{"name":"the Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang","award":["2019R01007"],"award-info":[{"award-number":["2019R01007"]}]},{"name":"Cancer Center, Zhejiang University and Key Research and Development Program of Zhejiang Province","award":["2020C03002"],"award-info":[{"award-number":["2020C03002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-026-01059-8","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T13:27:39Z","timestamp":1782048459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of gut microbiome signatures in metabolic dysfunction associated steatotic liver disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuyang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengya","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W.-S. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 71, 1851\u20131864 (2020).","journal-title":"Hepatology"},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jceh.2019.01.007","volume":"9","author":"B Ching-Yeung Yu","year":"2019","unstructured":"Ching-Yeung Yu, B., Kwok, D. & Wong, V. W.-S. Magnitude of nonalcoholic fatty liver disease: eastern perspective. J. Clin. Exp. Hepatol. 9, 491\u2013496 (2019).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"1059_CR7","doi-asserted-by":"crossref","unstructured":"Loomba, R., Friedman, S.L., Shulman, G.I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target Ther. 7, 135 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1059_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1965463","volume":"13","author":"MAJ Hullar","year":"2021","unstructured":"Hullar, M. A. J. et al. Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study. Gut Microbes 13, 1965463 (2021).","journal-title":"Gut Microbes"},{"key":"1059_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37163-4","volume":"13","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Characteristics of gut microbiota in patients with metabolic-associated fatty liver disease. Sci. Rep. 13, 9988 (2023).","journal-title":"Sci. Rep."},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier, J. et al. The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63, 764\u2013775 (2016).","journal-title":"Hepatology"},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.26319","volume":"58","author":"M Mouzaki","year":"2013","unstructured":"Mouzaki, M. et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58, 120\u2013127 (2013).","journal-title":"Hepatology"},{"key":"1059_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03317-y","volume":"22","author":"F Zeng","year":"2024","unstructured":"Zeng, F. et al. Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults. BMC Med. 22, 104 (2024).","journal-title":"BMC Med."},{"key":"1059_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99\u2013103 (2013).","journal-title":"Nature"},{"key":"1059_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55\u201360 (2012).","journal-title":"Nature"},{"key":"1059_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.chom.2020.06.004","volume":"28","author":"S Reitmeier","year":"2020","unstructured":"Reitmeier, S. et al. Arrhythmic gut microbiome signatures predict risk of type 2 diabetes. Cell Host Microbe 28, 258\u2013272.e6 (2020).","journal-title":"Cell Host Microbe"},{"key":"1059_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0304-1","volume":"8","author":"C Zhang","year":"2016","unstructured":"Zhang, C. & Zhao, L. Strain-level dissection of the contribution of the gut microbiome to human metabolic disease. Genome Med. 8, 41 (2016).","journal-title":"Genome Med."},{"key":"1059_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 17, 279\u2013297 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrmicro.2016.83","volume":"14","author":"J Wang","year":"2016","unstructured":"Wang, J. & Jia, H. Metagenome-wide association studies: fine-mining the microbiome. Nat. Rev. Microbiol. 14, 508\u2013522 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446\u2013450 (2013).","journal-title":"Nature"},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1126\/science.1242674","volume":"341","author":"J Bollrath","year":"2013","unstructured":"Bollrath, J. & Powrie, F. Feed Your Tregs More Fiber. Science 341, 463\u2013464 (2013).","journal-title":"Science"},{"key":"1059_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00125-023-06032-0","volume":"67","author":"E Moens De Hase","year":"2024","unstructured":"Moens De Hase, E. et al. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention. Diabetologia 67, 333\u2013345 (2024).","journal-title":"Diabetologia"},{"key":"1059_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100437","volume":"64","author":"E Moens de Hase","year":"2023","unstructured":"Moens de Hase, E. et al. Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipids. J. Lipid Res. 64, 100437 (2023).","journal-title":"J. Lipid Res."},{"key":"1059_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2020-323778","volume":"71","author":"T Le Roy","year":"2022","unstructured":"Le Roy, T. et al. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice. Gut 71, 534\u2013543 (2022).","journal-title":"Gut"},{"key":"1059_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01797-x","volume":"12","author":"K Luo","year":"2024","unstructured":"Luo, K. et al. Gut microbiota, blood metabolites, and left ventricular diastolic dysfunction in US Hispanics\/Latinos. Microbiome 12, 85 (2024).","journal-title":"Microbiome"},{"key":"1059_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82947-1","volume":"11","author":"M Tabone","year":"2021","unstructured":"Tabone, M. et al. The effect of acute moderate-intensity exercise on the serum and fecal metabolomes and the gut microbiota of cross-country endurance athletes. Sci. Rep. 11, 3558 (2021).","journal-title":"Sci. Rep."},{"key":"1059_CR28","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/db15-0370","volume":"64","author":"J Cordoba-Chacon","year":"2015","unstructured":"Cordoba-Chacon, J. et al. Growth hormone inhibits hepatic de novo lipogenesis in adult mice. Diabetes 64, 3093\u20133103 (2015).","journal-title":"Diabetes"},{"key":"1059_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155589","volume":"144","author":"MC V\u00e1zquez-Borrego","year":"2023","unstructured":"V\u00e1zquez-Borrego, M. C. et al. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis. Metabolism 144, 155589 (2023).","journal-title":"Metabolism"},{"key":"1059_CR30","doi-asserted-by":"crossref","unstructured":"Xie, C. et al. Integrated analysis of multi-tissues lipidome and gut microbiome reveals microbiota-induced shifts on lipid metabolism in pigs. Anim. Nutr. 10, 280\u2013293 (2022).","DOI":"10.1016\/j.aninu.2022.04.011"},{"key":"1059_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pbi.2004.03.007","volume":"7","author":"AR Fernie","year":"2004","unstructured":"Fernie, A. R., Carrari, F. & Sweetlove, L. J. Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport. Curr. Opin. Plant Biol. 7, 254\u2013261 (2004).","journal-title":"Curr. Opin. Plant Biol."},{"key":"1059_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi3332","volume":"383","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG. Science 383, eadi3332 (2024).","journal-title":"Science"},{"key":"1059_CR33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos, A., de Gottardi, A. & Rescigno, M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J. Hepatol. 72, 558\u2013577 (2020).","journal-title":"J. Hepatol."},{"key":"1059_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.tem.2022.01.002","volume":"33","author":"J Martel","year":"2022","unstructured":"Martel, J. et al. Gut barrier disruption and chronic disease. Trends Endocrinol. Metab. 33, 247\u2013265 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"1059_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct. Target. Ther. 7, 287 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1059_CR36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/nu10111793","volume":"10","author":"M Krawczyk","year":"2018","unstructured":"Krawczyk, M. et al. Gut permeability might be improved by dietary fiber in individuals with nonalcoholic fatty liver disease (NAFLD) undergoing weight reduction. Nutrients 10, 1793 (2018).","journal-title":"Nutrients"},{"key":"1059_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/gutjnl-2018-317726","volume":"69","author":"J Tulkens","year":"2020","unstructured":"Tulkens, J. et al. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction. Gut 69, 191\u2013193 (2020).","journal-title":"Gut"},{"key":"1059_CR38","doi-asserted-by":"crossref","unstructured":"Ciesielska, A., Matyjek, M., Kwiatkowska, K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol. Life Sci. 78, 1233\u20131261 (2021).","DOI":"10.1007\/s00018-020-03656-y"},{"key":"1059_CR39","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cmet.2023.08.002","volume":"35","author":"Y Ni","year":"2023","unstructured":"Ni, Y. et al. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations. Cell Metab. 35, 1530\u20131547.e8 (2023).","journal-title":"Cell Metab."},{"key":"1059_CR40","doi-asserted-by":"crossref","unstructured":"Fukunshi, S. et al. Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats. J. Clin. Biochem. Nutr. 54, 39\u201344 (2014).","DOI":"10.3164\/jcbn.13-49"},{"key":"1059_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.plipres.2009.06.002","volume":"49","author":"X Wang","year":"2010","unstructured":"Wang, X. & Quinn, P. J. Lipopolysaccharide: biosynthetic pathway and structure modification. Prog. Lipid Res 49, 97\u2013107 (2010).","journal-title":"Prog. Lipid Res"},{"key":"1059_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-biochem-060713-035600","volume":"83","author":"C Whitfield","year":"2014","unstructured":"Whitfield, C. & Trent, M. S. Biosynthesis and export of bacterial lipopolysaccharides. Annu. Rev. Biochem. 83, 99\u2013128 (2014).","journal-title":"Annu. Rev. Biochem."},{"key":"1059_CR43","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.1021\/acs.jmedchem.4c00037","volume":"67","author":"F Moreau","year":"2024","unstructured":"Moreau, F. et al. Potentiating activity of GmhA inhibitors on gram-negative bacteria. J. Med. Chem. 67, 6610\u20136623 (2024).","journal-title":"J. Med. Chem."},{"key":"1059_CR44","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1128\/jb.178.11.3339-3341.1996","volume":"178","author":"JS Brooke","year":"1996","unstructured":"Brooke, J. S. & Valvano, M. A. Molecular cloning of the Haemophilus influenzae gmhA (lpcA) gene encoding a phosphoheptose isomerase required for lipooligosaccharide biosynthesis. J. Bacteriol. 178, 3339\u20133341 (1996).","journal-title":"J. Bacteriol."},{"key":"1059_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40104-019-0402-1","volume":"11","author":"P Guo","year":"2020","unstructured":"Guo, P., Zhang, K., Ma, X. & He, P. Clostridium species as probiotics: potentials and challenges. J. Anim. Sci. Biotechnol. 11, 24 (2020).","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"1059_CR46","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cmet.2023.12.027","volume":"36","author":"J She","year":"2024","unstructured":"She, J. et al. Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner. Cell Metab. 36, 408\u2013421.e5 (2024).","journal-title":"Cell Metab."},{"key":"1059_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1128\/MMBR.00062-12","volume":"77","author":"J Li","year":"2013","unstructured":"Li, J. et al. Toxin plasmids of Clostridium perfringens. Microbiol. Mol. Biol. Rev. 77, 208\u2013233 (2013).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1059_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/19490976.2017.1362526","volume":"9","author":"BR Anjuwon-Foster","year":"2018","unstructured":"Anjuwon-Foster, B. R. & Tamayo, R. Phase variation of Clostridium difficile virulence factors. Gut Microbes 9, 76\u201383 (2018).","journal-title":"Gut Microbes"},{"key":"1059_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen, Z. D. et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 13, 6958 (2022).","journal-title":"Nat. Commun."},{"key":"1059_CR50","doi-asserted-by":"publisher","first-page":"e0301446","DOI":"10.1371\/journal.pone.0301446","volume":"19","author":"TBN Jensen","year":"2024","unstructured":"Jensen, T. B. N., Dall, S. M., Knutsson, S., Karst, S. M. & Albertsen, M. High-throughput DNA extraction and cost-effective miniaturized metagenome and amplicon library preparation of soil samples for DNA sequencing. PLOS ONE 19, e0301446 (2024).","journal-title":"PLOS ONE"},{"key":"1059_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40793-022-00436-y","volume":"17","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Sequencing introduced false positive rare taxa lead to biased microbial community diversity, assembly, and interaction interpretation in amplicon studies. Environ. Microbiome 17, 43 (2022).","journal-title":"Environ. Microbiome"},{"key":"1059_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.107","volume":"2","author":"S Chen","year":"2023","unstructured":"Chen, S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. Imeta 2, e107 (2023).","journal-title":"Imeta"},{"key":"1059_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"1059_CR54","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","volume":"41","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez, A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633\u20131644 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1059_CR55","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021).","journal-title":"eLife"},{"key":"1059_CR56","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/bioinformatics\/btv033","volume":"31","author":"D Li","year":"2015","unstructured":"Li, D., Liu, C.-M., Luo, R., Sadakane, K. & Lam, T.-W. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics 31, 1674\u20131676 (2015).","journal-title":"Bioinformatics"},{"key":"1059_CR57","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s40168-018-0541-1","volume":"6","author":"GV Uritskiy","year":"2018","unstructured":"Uritskiy, G. V., DiRuggiero, J. & Taylor, J. MetaWRAP\u2014a flexible pipeline for genome-resolved metagenomic data analysis. Microbiome 6, 158 (2018).","journal-title":"Microbiome"},{"key":"1059_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07641-9","volume":"9","author":"C Jain","year":"2018","unstructured":"Jain, C., Rodriguez-R, L. M., Phillippy, A. M., Konstantinidis, K. T. & Aluru, S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat. Commun. 9, 5114 (2018).","journal-title":"Nat. Commun."},{"key":"1059_CR59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2019.01.001","volume":"176","author":"E Pasolli","year":"2019","unstructured":"Pasolli, E. et al. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell 176, 649\u2013662.e20 (2019).","journal-title":"Cell"},{"key":"1059_CR60","first-page":"000685","volume":"7","author":"O Schwengers","year":"2021","unstructured":"Schwengers, O. et al. Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification: find out more about Bakta, the motivation, challenges and applications, here. Microb. Genom. 7, 000685 (2021).","journal-title":"Microb. Genom."},{"key":"1059_CR61","doi-asserted-by":"publisher","first-page":"W484","DOI":"10.1093\/nar\/gkad326","volume":"51","author":"JR Grant","year":"2023","unstructured":"Grant, J. R. et al. Proksee: in-depth characterization and visualization of bacterial genomes. Nucleic Acids Res. 51, W484\u2013W492 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1059_CR62","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12275-018-8014-6","volume":"56","author":"S-I Na","year":"2018","unstructured":"Na, S.-I. et al. UBCG: Up-to-date bacterial core gene set and pipeline for phylogenomic tree reconstruction. J. Microbiol. 56, 280\u2013285 (2018).","journal-title":"J. Microbiol."},{"key":"1059_CR63","doi-asserted-by":"crossref","unstructured":"Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312-1313 (2014).","DOI":"10.1093\/bioinformatics\/btu033"},{"key":"1059_CR64","doi-asserted-by":"publisher","first-page":"e1002687","DOI":"10.1371\/journal.pcbi.1002687","volume":"8","author":"J Friedman","year":"2012","unstructured":"Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLOS Comput. Biol. 8, e1002687 (2012).","journal-title":"PLOS Comput. Biol."},{"key":"1059_CR65","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"1059_CR66","doi-asserted-by":"publisher","first-page":"D445","DOI":"10.1093\/nar\/gkz862","volume":"48","author":"R Caspi","year":"2020","unstructured":"Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes\u2014a 2019 update. Nucleic Acids Res. 48, D445\u2013D453 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1059_CR67","doi-asserted-by":"publisher","unstructured":"Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. In Proc. 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785\u2013794 https:\/\/doi.org\/10.1145\/2939672.2939785 (ACM, 2016).","DOI":"10.1145\/2939672.2939785"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01059-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:02:56Z","timestamp":1785906176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-01059-8","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"147"}}